Chengdu Kanghong Pharmaceuticals Group Co Ltd Capital Reinvestment Ratio
Chengdu Kanghong Pharmaceuticals Group Co Ltd capital reinvestment ratio. Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥504.02 Million) in capital expenditures (CN¥105.16 Million). Check Chengdu Kanghong Pharmaceuticals Group C cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Capital reinvestment ratio of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. This chart tracks Chengdu Kanghong Pharmaceuticals Group Co Ltd's Capital Reinvestment Ratio across 17 annual periods. Also explore Chengdu Kanghong Pharmaceuticals Group C annual equity growth to track the company's year-over-year net asset growth rate.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Capital Reinvestment Ratio by Year (2009–2025)
Chengdu Kanghong Pharmaceuticals Group Co Ltd capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see Chengdu Kanghong Pharmaceuticals Group C cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥1.50 Billion | CN¥262.48 Million | ▲ +54.6% |
| 2024 | 0.11x | CN¥1.41 Billion | CN¥159.39 Million | ▼ -1.0% |
| 2023 | 0.11x | CN¥1.22 Billion | CN¥138.87 Million | ▼ -70.3% |
| 2022 | 0.38x | CN¥925.15 Million | CN¥355.21 Million | ▼ -66.7% |
| 2021 | 1.15x | CN¥494.11 Million | CN¥569.42 Million | ▼ -49.0% |
| 2020 | 2.26x | CN¥273.32 Million | CN¥617.07 Million | ▲ +90.4% |
| 2019 | 1.19x | CN¥812.15 Million | CN¥962.88 Million | ▼ -9.3% |
| 2018 | 1.31x | CN¥350.88 Million | CN¥458.45 Million | ▲ +220.2% |
| 2017 | 0.41x | CN¥766.86 Million | CN¥312.88 Million | ▲ +102.9% |
| 2016 | 0.20x | CN¥846.35 Million | CN¥170.23 Million | ▼ -16.3% |
| 2015 | 0.24x | CN¥481.97 Million | CN¥115.83 Million | ▼ -22.4% |
| 2014 | 0.31x | CN¥291.38 Million | CN¥90.27 Million | ▲ +33.8% |
| 2013 | 0.23x | CN¥333.31 Million | CN¥77.16 Million | ▼ -49.6% |
| 2012 | 0.46x | CN¥281.84 Million | CN¥129.51 Million | ▼ -50.7% |
| 2011 | 0.93x | CN¥168.86 Million | CN¥157.25 Million | ▼ -3.3% |
| 2010 | 0.96x | CN¥136.79 Million | CN¥131.76 Million | ▼ -34.0% |
| 2009 | 1.46x | CN¥108.42 Million | CN¥158.27 Million | — |